Functional role of proinflammatory and anti-inflammatory cytokines in seizures

Advances in Experimental Medicine and Biology

Volumn 548, Issue , 2004, Pages 123-133

  Vezzani, Annamaria ^a   Moneta, Daniela ^a   Richichi, Cristina ^a   Perego, Carlo ^a   De Simoni, Maria G ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; CYTOKINE; GLUTAMIC ACID; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

BRAIN; BRAIN DEPTH STIMULATION; BRAIN NERVE CELL; CENTRAL NERVOUS SYSTEM; CONCENTRATION RESPONSE; HUMAN; MICROGLIA; NERVE CELL LESION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE; SYNAPTIC TRANSMISSION;

MUS MUSCULUS;

EID: 3242762980     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-6376-8_10     Document Type: Review

References (50)

1. Schöbitz B, Ron De Kloet E, Holsboer F. Gene expression and function of interleukin-1, interleukin-6 and tumor necrosis factor in the brain. Prog Neurobiol 1994; 44:397-432.
2. Hopkins SJ, Rothwell NJ. Cytokines and the nervous system I. Expression and recognition. Trends Neurosci 1995; 18:83-88.
3. Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: Actions and mechanisms of action. Trends Neurosci 1995; 18:130-136.
4. De Simoni MG, Imeri L. Cytokine-neurotransmitter interactions in the brain. Biol Signals 1998; 7:33-44.
5. Scarborough DE, Lee SL, Dinarcllo CA et al. Interleukin-1β stimulates somatostatin biosynthesis in primary cultures of fetal rat brain. Endocrinology 1986; 124:549-551.
6. Spranger M, Lindholm D, Bandtlow C et al. Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur J Neurosci 1990; 2:69-76.
7. Lapchak PA, Araujo DM. Hippocampal interleukin-2 regulates monoamine and opioid peptide release from the hippocampus. Neuroreport 1993; 4:303-306.
8. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nature Rev Neurosci 2001; 2:734-744.
9. Katsuki H, Nakai S, Hirai Y et al. Interleukin-1β inhibits long-term potentiation in the CA3 region of the mouse hippocampal slice. Eur J Pharmacol 1990; 181:323-326.
10. Bellinger FP, Madamba S, Siggins GR. Interleukin 1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res 1993; 628:227-234.
11. Cunningham AJ, Murray CA, O'Neil LAJ et al. Interleukin 1β and tumor necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 1996; 203:17-20.
12. Coogan A, O'Connor JJ. Inhibition of NMDA receptor-mediated synaptic transmission in the rat dentate gyrus in vitro by IL-1β. Neuroreport 1997; 8:2107-2110.
13. D'Arcangelo G, Dodt H, Zieglgansberger W. Reduction of excitation by interleukin-1β in rat neocortical slices visualized using infrared darkfield videomicroscopy. Neuroreport 1997; 8:2079-2083.
14. Zeise ML, Espinoza J, Morales P et al. Interleukin-1β does not increase synaptic inhibition in hippocampal CA3 pyramidal and dentate gyrus granule cells of the rat in vitro. Brain Res 1997; 768:341-344.
15. A) receptor current in cultured hippocampal neurons. J Pharmacol Exp Ther 2000; 292:497-504.
16. Miller LG, Galpern WG, Lumpkin M et al. Interleukin-1 (IL-1) augments gamma-aminobutyric acid receptor function in the brain. Mol Pharmacol 1991; 39:105-108.
17. Plata-Salaman CR, French-Mullen JMH. Interleukin-1β depresses calcium current in CA1 hippocampal neurons at pathophysiological concentrations. Brain Res Bull 1992; 29:221-223.
18. Minami M, Kuraishi Y, Satoh M. Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain. Biochem Biophys Res Commun 1991; 176:593-598.
19. Yabuuchi K, Minami M, Katsumata S et al. In situ hybridization study of interleukin-1β mRNA induced by kainic acid in the rat brain. Brain Res Mol Brain Res 1993; 20:153-161.
20. Nishiyori A, Minami M, Takami S et al. Type 2 interleukin-1 receptor mRNA is induced by kainic acid in the rat brain. Mol Brain Res 1997; 50:237-245.
21. Gahring LC, White SH, Skradski SL et al. Interleukin-1α in the brain is induced by audiogenic seizure. Neurobiol Dis 1997; 3:263-269.
22. Eriksson C, Winblad B, Schultzberg M. Immunohistochemical localization of interleukin-1beta, interleukin-1 receptor antagonist and interleukin-1beta converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid. Neuroscience 1999; 93:915-930.
23. Vezzani A, Conti M, De Luigi A et al. Interleukin-1β immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 1999; 19:5054-5065.
24. De Simoni MG, Perego C, Ravizza T et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000; 12:2623-2633.
25. Vezzani A, Moneta D, Conti M et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci USA 2000; 97:11534-11539.
26. Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function and mechanism of action. Am J Physiol 1992; 263:C1-C16.
27. Bartfai T, Shultzberg M. Cytokines in neuronal cell types. Neurochem Int 1993; 22:435-444.
28. Perry VH, Andersson PB, Gordon S. Macrophages and inflammation in the central nervous system. Trends Neurosci 1993; 16 (7):268-273.
29. Montero-Menei CN, Sindji L, Garcion E et al. Early events of the inflammatory reaction induced in rat brain by lipolysaccharide intracerebral injection: relative contribution of peripheral monocytes and activated microglia. Brain Res 1996; 724:55-66.
30. Zhao B, Schwartz JP. Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspective. J Neurosci Res 1998; 52:7-16.
31. Nitsch C, Goping G, Klatzo I. Pathophysiological aspects of blood brain barrier permeability in epileptic seizures. In: Schwarcz R, Ben-Ari Y, eds. Advances in Experimental Medicine and Biology. New York, London: 1986:175-184.
32. Jander S, Schroeter M, Stoll G. Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia. J Neuroimmunol 2000; 109:181-187.
33. Kamikawa H, Hori T, Nakane H et al. IL-1β increases norepinephrine level in the rat frontal cortex: involvement of prostanoids, NO, and glutamate: Am J Physiol 1998; 275:R806-R810.
34. Ye ZC, Sontheimer H. Cytokine modulation of glial glutamate uptake: a possible involvement of nitric oxide. Neuroreport 1996; 72:181-2185.
35. Luk WP, Zhang Y, White TD et al. Adenosine: a mediator of interleukin-1β induced hippocampal synaptic inhibition. J Neurosci 1999; 19:4238-4244.
36. Campbell IL, Abraham CR, Masliah E et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 1993; 90:10061-10065.
37. Akassoglou K, Probert L, Kontogeorgos G et al. Astrocyte-specific but not neuron specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol 1997; 158:438-445.
38. Vezzani A, Moneta D, Richichi C et al. Functional role of TNF-α and IL-1β systems in seizure susceptibility and epileptogenesis. 31st Annual meeting Society for Neuroscience Nov 10-15 2001; 557:18.
39. Bruce AJ, Boling W, Kindy MS. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med 1996; 2:788-794.
40. Sheng JG, Boop FA, Mrak RE et al. Increased neuronal β-amyloid precursor protein expression in human temporal lobe epilepsy, association with interleukin-1α immunoreactivity. J Neurochem 1994; 63:1872-1879.
41. Barres BA. New roles for microglia. J Neurosci 1991; 11:3685-3694.
42. Peltola J, Palmio J, Korhonen L. Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res 2000; 41:205-211.
43. Lahat E, Livine M, Barr J. Interleukin-1 levels in serum and cerebrospinal fluid of children with febrile seizures. Pediatr Neurol 1997; 17:34-36.
44. Ichiyama T, Nishikawa M, Yoshitomi T. Tumor necrosis factor-α, interleukin-1, and interleukin-6 in cerebrospinal fluid from children with prolonged seizures. Neurology 1998; 50:407-411.
45. Kanemoto K, Kawasaki J, Miyamoto T. Interleukin(IL)-1β, IL-1α, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol 2000; 47:571-574.
46. Hurme VM, Helminen M. Increased frequency of interleukin-1beta (-511) allele 2 in febrile seizures. Pediatr Neurol 2002; 26:192-195.
47. de Bock F, Dornand J, Rondouin G. Release of TNF in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage. Neuroreport 1996; 7:1125-1129.
48. Takao T, Tracey DE, Mitchell WM. Interleukin-1 receptors in mouse brain: Characterization and neuronal localization. Endocrinology 1990; 127:3070-3078.
49. Ban E, Milon G, Prudhomme N et al. Receptors for interleukin-1 (alpha and beta) in mouse brain: Mapping and neuronal localization in hippocampus. Neuroscience 1991; 43:21-30.
50. Dinarello CA. Biological basis for interleukin-1 in disease. Blood 1996; 87:2095-2147.